Drug prices: Another way to interpret negotiations for cost

Under the administration of President Joe Biden, there were a number of provisions beneficial to senior patients through the Inflation Reduction Act. The Alliance for Aging Research (AAR) supports those, said Adina Lasser AAR director of public policy and government affairs. But there is a nuance: the Medicare Drug Price Negotiation Program has no mechanism for passing along savings to beneficiaries at the pharmacy counter.